ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,390,451, issued on Aug. 19, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium).
"Small molecule inhibitor of the JAK family of kinases" was invented by Edward F. Attiyeh (Villanova, Pa.), Kurtis E. Bachman (Chester Springs, Pa.), Gerald C. Chu (Philadelphia), Tatiana Koudriakova (Poway, Calif.), David C. Polidori (Rancho Santa Fe, Calif.) and Gary V. Borzillo (Upper Gwynedd, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are JAK inhibitors that have low systemic toxicity. In some aspects, the disclosure includes methods for treating disease states, disorders, and conditions mediated by JAK, such as stomacho-intestinal system...